Large dose procainamide therapy for ventricular tachyarrhythmia.
D000328:Adult; D000368:Aged; D000855:Anorexia / Q000139:chemically induced; D000974:Antibodies, Antinuclear; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000139:chemically induced; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010349:Patient Compliance; D011342:Procainamide / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors
D000974:Antibodies, Antinuclear; D011342:Procainamide